当前位置:首页 - 行情中心 - 健帆生物(300529) - 财务分析 - 现金流量表

健帆生物

(300529)

  

流通市值:108.66亿  总市值:169.62亿
流通股本:5.12亿   总股本:7.99亿

现金流量表

报告期2025-06-302025-03-312024-12-312024-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金1,299,776,192.19605,506,283.552,968,564,959.492,308,282,415.79
  收到的税费返还797,579.13427,508.821,412,149.211,426,857.54
  收到其他与经营活动有关的现金102,177,855.852,637,880.561,223,715.0756,838,321.8
  经营活动现金流入小计1,402,751,627.12658,571,672.873,031,200,823.772,366,547,595.13
  购买商品、接受劳务支付的现金188,856,764.35108,555,827.23337,539,883.33281,607,229.43
  支付给职工以及为职工支付的现金290,208,099.41133,698,395.11619,071,241.96451,803,005.36
  支付的各项税费214,627,171.3669,901,768.04469,527,502.11357,955,996.27
  支付其他与经营活动有关的现金170,778,156.6177,361,893.68554,073,774.97403,576,558.51
  经营活动现金流出小计864,470,191.73389,517,884.061,980,212,402.371,494,942,789.57
  经营活动产生的现金流量净额538,281,435.39269,053,788.811,050,988,421.4871,604,805.56
二、投资活动产生的现金流量:
  收回投资收到的现金1,778,730,364.61649,212,907.893,732,950,0001,545,083,634.46
  取得投资收益收到的现金8,378,243.26619,349.8942,089,876.6324,463,713.3
  处置固定资产、无形资产和其他长期资产收回的现金净额1,665,940.291,454,9505,340,781.354,889,381.35
  投资活动现金流入小计1,788,774,548.16651,287,207.783,780,380,657.981,574,436,729.11
  购建固定资产、无形资产和其他长期资产支付的现金88,819,929.4152,431,942.8235,140,028.4179,475,487.15
  投资支付的现金2,589,950,0002,129,950,0004,672,712,907.893,572,712,907.89
  投资活动现金流出小计2,678,769,929.412,182,381,942.84,907,852,936.293,752,188,395.04
  投资活动产生的现金流量净额-889,995,381.25-1,531,094,735.02-1,127,472,278.31-2,177,751,665.93
三、筹资活动产生的现金流量:
  吸收投资收到的现金---0
  取得借款收到的现金45,151,704.6634,691,084.41325,075,677.25294,425,852.51
  收到其他与筹资活动有关的现金28,796,931.828,380,023.6694,342,749.3650,000,000
  筹资活动现金流入小计73,948,636.4843,071,108.07419,418,426.61344,425,852.51
  偿还债务支付的现金32,110,857.4416,530,548.64651,161,297.67364,161,297.67
  分配股利、利润或偿付利息支付的现金639,269,472.461,373,115.22340,117,509.67334,666,001.54
  支付其他与筹资活动有关的现金30,041,154.449,224,864.26417,960,680.74373,288,104.48
  筹资活动现金流出小计701,421,484.3427,128,528.121,409,239,488.081,072,115,403.69
  筹资活动产生的现金流量净额-627,472,847.8615,942,579.95-989,821,061.47-727,689,551.18
四、汇率变动对现金及现金等价物的影响93,947.11145,379.17427,871.75-787,737.51
五、现金及现金等价物净增加额-979,092,846.61-1,245,952,987.09-1,065,877,046.63-2,034,624,149.06
  加:期初现金及现金等价物余额1,675,666,241.251,675,666,241.252,741,543,287.882,741,543,287.88
  期末现金及现金等价物余额696,573,394.64429,713,254.161,675,666,241.25706,919,138.82
补充资料:
  净利润388,668,556.92-814,186,376.79-
  资产减值准备3,760,902.26-10,843,712.79-
  固定资产和投资性房地产折旧58,730,030.61-119,604,861.51-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧58,730,030.61-119,604,861.51-
  无形资产摊销2,156,071.63-4,311,430.23-
  长期待摊费用摊销8,569,780.78-16,954,528.37-
  处置固定资产、无形资产和其他长期资产的损失1,413,498.67--3,639,820.27-
  固定资产报废损失682,958.8-1,041,823.84-
  公允价值变动损失-21,552,025.71--1,023,228.9-
  财务费用26,807,559.18-63,713,298.39-
  投资损失-8,330,958.77--42,089,876.63-
  递延所得税-16,190,686.97--5,476,591.81-
  其中:递延所得税资产减少-19,190,904.39--4,233,114.23-
    递延所得税负债增加3,000,217.42--1,243,477.58-
  存货的减少3,277,523.29-41,562,239.31-
  经营性应收项目的减少5,518,555.37--8,217,395.2-
  经营性应付项目的增加65,044,209.58-451,180.84-
  其他18,574,999.98-35,486,882.63-
  现金的期末余额696,573,394.64-1,675,666,241.25-
  减:现金的期初余额1,675,666,241.25-2,741,543,287.88-
  现金及现金等价物的净增加额-979,092,846.61--1,065,877,046.63-
公告日期2025-08-222025-04-162025-04-162024-10-19
审计意见(境内)标准无保留意见
TOP↑